Kids Are Watching How We Use Our Phones

kids-are-watching-how-we-use-our-phones.pngAs parents, there are a million different ways to feel bad or guilty. The amount of time most of us spend on our phone in front of our kids can be one of them. The good news is, changing is easier than you may think. All the details of our lives are held in our phones. Work schedules, texts, and even some relationships are dependent on having our phones on us constantly. This isn’t necessarily a bad thing – it just shows how busy our lives have gotten. Here’s the kicker – it can turn into an addiction without us knowing it, but our kids certainly do. It may sound extreme calling our dependence on phones an addiction, but scientific studies say otherwise.
“Still, there’s plenty of research out there describing the dopamine effect—a neurotransmitter that sends pulses to your brain’s reward and pleasure centers with every new text or tweet—and the widespread addiction to that momentary pleasure, which has been compared to cravings for nicotine, cocaine, and gambling.”
Kids can feel your interest shift from them to the phone – or perhaps it was always on your phone. It’s okay that this happens because it’s fixable.
“Demonstrate your own mindfulness in front of your children by putting down your phone during meals or whenever they need your attention.” – David Hill
Motherly.com has 4 recommendations that can help fix our phone addiction issues.

1. Take Stock of Your Actual Phone Needs 

kids-are-watching-how-we-use-our-phones-1.pngkids-are-watching-how-we-use-our-phones-1.png Tim Harford writes that “smartphones are habit-forming, so think about the habits you want to form.” Most adults legitimately need their phones. But, if we’re honest, we don’t need it every second we’re at home with the kids. To help set limits, writing a list of all the activities you need your phone for can help you prioritize what’s fun vs. critical while with the kids. Learn how you really use your phone while making sure it’s not using you.

2. Involve the Kids in a Family Discussion About Appropriate Smartphone Use 

Kids can contribute more to the conversation about what they think is appropriate screen time amounts. This will help them communicate with you when they’d like your attention and give you an opportunity to explain why you need to be on your phone at certain times.

 3. Write and Post Smartphone Rules Where Everyone Can See Them 

Motherly.com recommends these rules be where everyone can see them, e.g. the fridge. They’ll be different for every family, but examples might include:
  • No phones out for the first hour after coming home
  • No phones out until the kids are in bed
  • No phones out during meals
  • No phones out during a family movie

 4. Give Kids Ten Minutes of Undivided Positive Attention 

A super simple rule to implement in your everyday life is this: give your kids 10 minutes of undivided attention twice a day. Playing, talking, and just being with them without interruptions supports positive and emotional connections. While your kids are in front of their screens (we all are a few hours every day), make sure their eyes are protected. Learn more here. 

https://www.lvcenter4sight.com/kids-are-watching-how-we-use-our-phones/

Comments

Post a Comment

Popular posts from this blog

FDA Authorizes Clinical Trial for CRISPR/Cas9 Therapy for LCA 10

Editas Medicine , a company developing gene-editing treatments, has received authorization from the US Food and Drug Administration to launch a clinical trial for its emerging CRISPR/Cas9 therapy for people with a mutation in the gene CEP290, which causes Leber congenital amaurosis 10 (LCA10). LCA causes severe vision loss or blindness at birth. Known as EDIT-101, the treatment will be evaluated in a Phase 1/2, dose-escalation clinical trial.  The company expects to enroll 10 to 20 patients. Further details and contact information for the study will be listed soon at www.clinicaltrials.gov . EDIT-101 targets a specific mutation, “c.2991+1655A>G” in intron 26, of the CEP290 gene. Editas has earned a $25 million milestone payment from Allergan as part of a drug-development alliance. “We are very pleased with this historic milestone in the treatment of inherited retinal diseases,” says Stephen Rose, PhD, chief scientific officer, Foundation Fighting Blindness. “EDIT-101 is the fi...
Read more

Cataract Surgery Leads to Longer Life in Women

Image
Written by Dr. David Evans Last modified on September 6, 2018 An article I wrote back in April described a National Bureau of Economic Research study that concluded cataract surgery patients have a life expectancy 1.8 years longer than people with cataracts who do not undergo surgery. Much of that piece focused on the finding that people, who have vision diminished by cataracts, are less likely to be active, and more likely to suffer accidental falls and related injuries. As a follow-on, a new study published in JAMA Ophthalmology suggests an even stronger link between cataract surgery and mortality risk. About the Study The genesis of this study was something completely different than evaluating effects of cataract vision loss. Its original purpose was to evaluate the effects of hormone therapy and dietary changes in postmenopausal women. That study was cut short once it was determined that hormone therapy increased the risk of vascular events. Although the hormone therapy aspect ...
Read more

Vision Improvements Reported in ProQR’s Clinical Trial for LCA10 Treatment

Image
ProQR, a biotech company in the Netherlands, ha s reported vision improvements for patients in a  Phase 1/2 clinical trial for QR-110 , a therapy for people with  Leber congenital amaurosis  10 (LCA10), which is caused by the p.Cys998X mutation in the CEP290 gene. The mutation is estimated to affect about 2,000 people in the Western world. The company reported that 60 percent of su bjects in the trial demonstrated improvements in visual acuity and their ability to navigate a mobility course . The treatment was also safe for patients. As a result of the encouraging interim results, ProQR has concluded the Phase 1/2 trial and plans to move the treatment into a Phase 2/3 clinical trial. Ten people were treated in the Phase 1/2 study. Results from the interim analy sis were presented on September 5, 2018, at the Retinal Degeneration 2018 meeting in Killarney,   Ireland , by principal investigator   Artur Cideciyan , PhD , research professor of ophthalmology at the   Scheie Eye Ins...
Read more